First Trust Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-65,442
| Closed | -$1.33M | – | 2556 |
|
|
2024
Q4 | $1.33M | Buy |
65,442
+47,308
| +261% | +$964K | ﹤0.01% | 1961 |
|
|
2024
Q3 | $528K | Sell |
18,134
-1,116
| -6% | -$32.5K | ﹤0.01% | 2164 |
|
|
2024
Q2 | $447K | Buy |
+19,250
| New | +$447K | ﹤0.01% | 2150 |
|
|
2022
Q2 | – | Sell |
-14,224
| Closed | -$458K | – | 2513 |
|
|
2022
Q1 | $458K | Sell |
14,224
-923
| -6% | -$29.7K | ﹤0.01% | 2274 |
|
|
2021
Q4 | $676K | Sell |
15,147
-65,306
| -81% | -$2.91M | ﹤0.01% | 2199 |
|
|
2021
Q3 | $4.06M | Buy |
80,453
+19,135
| +31% | +$965K | ﹤0.01% | 1447 |
|
|
2021
Q2 | $4.81M | Buy |
61,318
+17,547
| +40% | +$1.38M | 0.01% | 1385 |
|
|
2021
Q1 | $2.5M | Sell |
43,771
-135,633
| -76% | -$7.74M | ﹤0.01% | 1633 |
|
|
2020
Q4 | $15M | Buy |
179,404
+39,873
| +29% | +$3.34M | 0.02% | 709 |
|
|
2020
Q3 | $5M | Buy |
139,531
+98,673
| +242% | +$3.54M | 0.01% | 965 |
|
|
2020
Q2 | $988K | Buy |
40,858
+7,979
| +24% | +$193K | ﹤0.01% | 1738 |
|
|
2020
Q1 | $576K | Buy |
+32,879
| New | +$576K | ﹤0.01% | 1880 |
|
|
2019
Q4 | – | Sell |
-72,102
| Closed | -$1.11M | – | 2399 |
|
|
2019
Q3 | $1.11M | Buy |
+72,102
| New | +$1.11M | ﹤0.01% | 1829 |
|